Raia Drogasil (BSP:RADL3) E10: R$0.59 (As of Mar. 2026)


BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$17.35
GF Value R$29.94
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil E10?

Raia Drogasil BSP:RADL3 +0.87% 91 E10 is R$0.59 as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.94 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Raia Drogasil's adjusted earnings per share data for the three months ended in Mar. 2026 was R$0.094. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$0.59 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Raia Drogasil's average E10 Growth Rate was 5.40% per year. During the past 3 years, the average E10 Growth Rate was 12.30% per year. During the past 5 years, the average E10 Growth Rate was 16.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Raia Drogasil was 21.10% per year. The lowest was 12.30% per year. And the median was 18.35% per year.

As of today (2026-06-28), Raia Drogasil's current stock price is R$17.35. Raia Drogasil's E10 for the quarter that ended in Mar. 2026 was R$0.59. Raia Drogasil's Shiller PE Ratio of today is 29.41.

During the past 13 years, the highest Shiller PE Ratio of Raia Drogasil was 101.81. The lowest was 23.27. And the median was 62.30.


Raia Drogasil  (BSP:RADL3) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Raia Drogasil's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=17.35/0.59
=29.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Raia Drogasil was 101.81. The lowest was 23.27. And the median was 62.30.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Raia Drogasil E10 Related Terms


Raia Drogasil E10 Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil E10 Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.34 0.41 0.48 0.55 0.58

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.57 0.59 0.58 0.59

Raia Drogasil E10 Competitor Comparison

For the Pharmaceutical Retailers subindustry, Raia Drogasil's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raia Drogasil Shiller PE Ratio vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Raia Drogasil's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Raia Drogasil's Shiller PE Ratio falls into.


BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Raia Drogasil's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.094/175.0655*175.0655
=0.094

Current CPI (Mar. 2026) = 175.0655.

Raia Drogasil Quarterly Data

per share eps CPI Adj_EPS
201606 0.089 108.851 0.143
201609 0.066 109.986 0.105
201612 0.050 110.802 0.079
201703 0.059 111.869 0.092
201706 0.079 112.115 0.123
201709 0.078 112.777 0.121
201712 0.076 114.068 0.117
201803 0.069 114.868 0.105
201806 0.078 117.038 0.117
201809 0.073 117.881 0.108
201812 0.067 118.340 0.099
201903 0.051 120.124 0.074
201906 0.079 120.977 0.114
201909 0.263 121.292 0.380
201912 0.049 123.436 0.069
202003 0.071 124.092 0.100
202006 0.127 123.557 0.180
202009 0.088 125.095 0.123
202012 0.092 129.012 0.125
202103 0.099 131.660 0.132
202106 0.144 133.871 0.188
202109 0.088 137.913 0.112
202112 0.097 141.992 0.120
202203 0.080 146.537 0.096
202206 0.210 149.784 0.245
202209 0.128 147.800 0.152
202212 0.169 150.207 0.197
202303 0.112 153.352 0.128
202306 0.198 154.519 0.224
202309 0.153 155.464 0.172
202312 0.173 157.148 0.193
202403 0.110 159.372 0.121
202406 0.112 161.052 0.122
202409 0.198 162.342 0.214
202412 0.208 164.740 0.221
202503 0.097 168.102 0.101
202506 0.221 169.670 0.228
202509 0.268 170.739 0.275
202512 0.196 171.765 0.200
202603 0.094 175.066 0.094

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of R$0.59 mean?
Raia Drogasil (BSP:RADL3) has a E10 of R$0.59 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's E10 too high?
Raia Drogasil's current E10 is R$0.59. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's E10 compare to competitors?
Raia Drogasil's E10 of R$0.59 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Healthcare Providers & Services company?
A good E10 depends on the Healthcare Providers & Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current E10 is R$0.59. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.94, compared to a current price of R$17.35 — trading 42.1% below its estimated fair value. The current E10 is R$0.59. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current E10 is R$0.59 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$17.35 is trading 42.1% below its estimated GF Value™ of R$29.94. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • E10: R$0.59
  • GF Value™: R$29.94 vs. price of R$17.35 (42.1% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$17.35
Price
R$29.94
GF Value